What This Bill Does · Plain English
Summary · Congress.gov
Servicewomen and Veterans Menopause Research Act This bill requires the Department of Defense (DOD) to coordinate with the Department of Veterans Affairs (VA) to evaluate and report on research related to menopause, perimenopause, or mid-life women’s health among members and former members of the uniformed services (i.e., Army, Navy, Air Force, Marine Corps, Space Force, Coast Guard, the commissioned corps of the Public Health Service, and the commissioned corps of the National Oceanic and Atmospheric Administration). Such evaluation must also examine (1) any gaps in knowledge and research on menopause treatments and the relation of service in the uniformed services to perimenopause and menopause, (2) the availability and uptake of professional training resources for DOD- or VA-employed providers relating to mid-life women’s health, and (3) the availability of and uptake of treatments for women in the uniformed services or veterans who are experiencing perimenopause or menopause. The report must include a strategic plan that resolves the gaps in knowledge and research.
Action Timeline
2025-12-02
Placed on Senate Legislative Calendar under General Orders. Calendar No. 275.
2025-12-02
Committee on Veterans' Affairs. Reported by Senator Moran with amendments. Without written report.
2025-12-02
Committee on Veterans' Affairs. Reported by Senator Moran with amendments. Without written report.
2025-07-30
Committee on Veterans' Affairs. Ordered to be reported with amendments favorably.
2025-05-21
Committee on Veterans' Affairs. Hearings held. Hearings printed: S.Hrg. 119-86.
2025-04-08
Read twice and referred to the Committee on Veterans' Affairs.
2025-04-08
Introduced in Senate
Frequently Asked Questions
Did S.1320 pass?
S.1320 is still alive. Current stage: REPORTED. Pass likelihood: 48%.
What does S.1320 do?
Servicewomen and Veterans Menopause Research Act This bill requires the Department of Defense (DOD) to coordinate with the Department of Veterans Affairs (VA) to evaluate and report on research related to menopause, perimenopause, or mid-life women’s health among members and former members of the uniformed services (i.e., Army, Navy, Air Force, Marine Corps, Space Force, Coast Guard, the commissioned corps of the Public Health Service, and the commissioned corps of the National Oceanic and Atmospheric Administration). Such evaluation must also examine (1) any gaps in knowledge and research on …
Who sponsored S.1320?
S.1320 was sponsored by Patty Murray (D-Washington).
Full Bill Text
119 S1320 RS: Servicewomen and Veterans Menopause Research Act U.S. Senate 2025-04-08 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. II Calendar No. 275 119th CONGRESS 1st Session S. 1320 IN THE SENATE OF THE UNITED STATES April 8, 2025 Mrs. Murray (for herself, Ms. Ernst , Mr. Justice , Mr. Ossoff , Mr. Cassidy , Mrs. Shaheen , Mrs. Gillibrand , Mr. Hickenlooper , Ms. Klobuchar , and Mr. Moran ) introduced the following bill; which was read twice and referred to the Committee on Veterans' Affairs December 2, 2025 Reported by Mr. Moran , with amendments Omit the parts struck through and insert the parts printed in italic A BILL To direct the Secretary of Defense and the Secretary of Veterans Affairs to take certain steps regarding research related to menopause, perimenopause, or mid-life women’s health, and for other purposes. 1. Short title This Act may be cited as the Servicewomen and Veterans Menopause Research Act . 2. Definitions In this Act: (1) Covered provider The term covered provider means a health care provider employed by the Department of Defense or the Department of Veterans Affairs. (2) Menopause The term menopause means the stage of a woman’s life— (A) when menstrual periods stop permanently and she can no longer get pregnant; and (B) that is not a disease state, but a normal part of aging for women. (3) Mid-life The term mid-life means a life stage that— (A) coincides with the menopausal transition in women, which may be physical or emotional; (B) encompasses the late reproductive age, which can begin at approximately 35 years of age, to the late postmenopausal stages of reproductive aging, which can extend to approximately 65 years of age; and (C) often marks the onset of many chronic diseases. (4) Perimenopause The term perimenopause means the time during a woman's life when levels of the hormone estrogen fall unevenly in a woman’s body and is also called the menopausal transition. (5) Postmenopausal The term postmenopausal means the stage of a woman's life after a woman has been without a menstrual period for 12 months that lasts for the rest of a woman’s life and reflects a time when women are at increased risk for osteoporosis and heart disease. 3. Evaluation of certain research related to menopause, perimenopause, or mid-life women’s health (a) In general The Secretary of Defense, in coordination with Secretary of Veterans Affairs, shall evaluate— (1) the results of completed research related to menopause, perimenopause, or mid-life women’s health among women who are members of the Armed Forces uniformed services or veterans; (2) the status of such research that is ongoing; (3) any gaps in knowledge and research on— (A) treatments for menopause-related symptoms, including hormone and non-hormone treatments; (B) the safety and effectiveness of treatments for menopause-related symptoms; (C) the relation of service in the Armed Forces uniformed services to perimenopause and menopause and the impact of such service on perimenopause and menopause; (D) the effect of combat roles on symptoms relating to perimenopause and menopause, including exposure to burn pits, toxic chemicals, and perfluoroalkyl and polyfluoroalkyl substances (commonly known as PFAS ); and (E) the impact of perimenopause and menopause on the mental health of women who are members of the Armed Forces uniformed services or veterans; (4) the availability of and uptake of professional training resources for covered providers relating to mid-life women’s health with respect to the care, treatment, and management of perimenopause and menopausal symptoms, and related support services; and (5) the availability of and uptake of treatments for women who are members of the Armed Forces uniformed services or veterans who are experiencing perimenopause or menopause. (b) Report; strategic plan Not later than 180 days after the date of the enactment of this Act, the Secretary of Defense and the Secretary of Veterans Affairs shall each submit to Congress a report containing— (1) the findings of the evaluation conducted under subsection (a); (2) recommendations for improving professional training resources described in subsection (a)(4) for covered providers; and (3) a strategic plan that— (A) resolves the gaps in knowledge and research identified in the report; and (B) identifies topics in need of further research relating to potential treatments for menopause-related symptoms of women who are members of the Armed Forces uniformed services or veterans. (c) Nonduplication and supplementation of efforts In carrying out activities under this section, the Secretary of Defense and the Secretary of Veterans Affairs shall ensure that such activities minimize duplication and supplement, not supplant, existing information-sharing efforts of the Department of Health and Human Services. 4. Sense of Congress on additional research related to menopause, perimenopause, or mid-life women’s health It is the sense of Congress that the Secretary of Defense and the Secretary of Veterans Affairs should each conduct research related to menopause, perimenopause, or mid-life health regarding women who are members of the Armed Forces uniformed services or veterans. December 2, 2025 Reported with amendments
Loading intelligence layer…